Major Groups Calling for Biosimilar Naming Reform
With a coalition of 32 major pharmacies, health insurers, unions, and pension plans asking the FDA not to require distinct names for biosimilar medications, changes could be coming for all pharmaceutical branding efforts. Some of the larger entities supporting the change include two large unions–AFL-CIO and AFSCME; and two of the largest pharmacy benefit managers–CVS Caremark and Express Scripts.
Brandsymbol Partners with Med-ERRS to Cultivate Safe Pharmaceutical Trademarks
Charlotte, NC – July 9, 2014 – Brandsymbol, a global branding agency, has partnered with Med-ERRS, an organization that works with the healthcare industry to prevent medication errors, in order to provide world-class pharmaceutical branding and safety testing to their clients.
Brands Battle at the FIFA World Cup
With The World Cup currently in full swing, nearly every brand is attempting to leverage the world’s largest sporting event in some form or fashion, from the hilariously misinformed, to the borderline irreverent. Continue reading
New FDA Guidance
Last week the FDA released its highly anticipated draft guidance outlining new recommended best practices for trademark name development. The guidance is titled, “Best Practices in Developing Proprietary Names for Drugs.” Our partners, Med-ERRS plan to submit comments to the docket and have already Continue reading
Welcome Summer Interns
Kaitlyn Lahm is currently a senior at Appalachian State University and is expected to graduate in May with a degree in public relations as well as a minor in dance. At Appalachian, Kaitlyn serves as a Student Ambassador by giving campus tours, working with the Alumni Association, and serving the Chancellor’s Continue reading